Moderna says its COVID-19 vaccine shows promise in elderly patients
The Pharma Data
AUGUST 27, 2020
Moderna has announced that its coronavirus vaccine candidate has shown promise in generating an immune response in elderly patients in an early-stage clinical trial. . The company has already tested the treatment on 10 adults between the ages of 56-70, and 10 over 71. Conor Kavanagh. Source link.
Let's personalize your content